News from the FDA/CDC

FDA authorizes Pfizer antiviral pill for COVID-19

Publish date: December 22, 2021

 

A version of this article first appeared on WebMD.com.

Pages

Recommended Reading

COVID cases spike as questions remain about Omicron’s threat
Covid ICYMI
Pfizer COVID vaccine for younger children hits snag
Covid ICYMI
CDC supports ‘test-to-stay’ for COVID- exposed students
Covid ICYMI
Emergency docs cite ‘dire’ situation as COVID grows, nurses scarce
Covid ICYMI
Axilla swelling after COVID booster puts focus on mammogram timing
Covid ICYMI
BMJ slams ‘incompetent’ Facebook fact-checking of vaccine article
Covid ICYMI
RSV resurgence likely in wake of COVID-19
Covid ICYMI
Children and COVID: New cases up slightly, vaccinations continue to slow
Covid ICYMI
Bamlanivimab’s effects in COVID-19 depend on antibodies
Covid ICYMI
Pandemic poses short- and long-term risks to babies, especially boys
Covid ICYMI